SG Americas Securities LLC Has $154,000 Position in Bath & Body Works, Inc. (NYSE:BBWI)

Posted by Defense World Staff on May 14th, 2023

SG Americas Securities LLC lessened its position in Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) by 83.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,653 shares of the company’s stock after selling 18,773 shares during the period. SG Americas Securities LLC’s holdings in Bath & Body Works were worth $154,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. State Street Corp boosted its holdings in Bath & Body Works by 0.6% in the third quarter. State Street Corp now owns 10,038,767 shares of the company’s stock worth $327,264,000 after acquiring an additional 58,201 shares in the last quarter. Third Point LLC purchased a new stake in Bath & Body Works in the third quarter worth $265,201,000. Price T Rowe Associates Inc. MD boosted its holdings in shares of Bath & Body Works by 8.2% in the second quarter. Price T Rowe Associates Inc. MD now owns 6,364,253 shares of the company’s stock worth $171,326,000 after acquiring an additional 484,674 shares during the period. Balyasny Asset Management LLC bought a new position in shares of Bath & Body Works in the third quarter worth $94,163,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of Bath & Body Works by 34.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,830,984 shares of the company’s stock worth $135,321,000 after acquiring an additional 726,384 shares during the period. Institutional investors own 96.34% of the company’s stock.

Wall Street Analyst Weigh In

BBWI has been the topic of a number of research reports. Jefferies Financial Group raised their price target on Bath & Body Works from $45.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday, January 31st. Deutsche Bank Aktiengesellschaft decreased their target price on Bath & Body Works from $55.00 to $47.00 in a research report on Friday, February 24th. Wells Fargo & Company decreased their target price on Bath & Body Works from $46.00 to $40.00 and set an “equal weight” rating for the company in a research report on Monday, April 10th. Raymond James downgraded Bath & Body Works from a “strong-buy” rating to an “outperform” rating and cut their price target for the stock from $50.00 to $48.00 in a research note on Thursday, April 6th. Finally, Barclays cut their target price on Bath & Body Works from $44.00 to $37.00 in a research note on Tuesday, May 2nd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Bath & Body Works currently has an average rating of “Hold” and an average price target of $47.90.

Insiders Place Their Bets

In other Bath & Body Works news, CFO Wendy C. Arlin sold 1,625 shares of the business’s stock in a transaction that occurred on Tuesday, March 28th. The stock was sold at an average price of $38.29, for a total transaction of $62,221.25. Following the sale, the chief financial officer now directly owns 91,072 shares of the company’s stock, valued at $3,487,146.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.37% of the stock is currently owned by insiders.

Bath & Body Works Trading Up 2.4 %

Shares of BBWI stock opened at $33.00 on Friday. Bath & Body Works, Inc. has a 12-month low of $25.75 and a 12-month high of $51.58. The stock’s 50-day moving average price is $35.58 and its 200-day moving average price is $39.38. The stock has a market capitalization of $7.55 billion, a price-to-earnings ratio of 9.57, a price-to-earnings-growth ratio of 0.88 and a beta of 1.70.

Bath & Body Works (NYSE:BBWI – Get Rating) last issued its earnings results on Thursday, February 23rd. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.63 by $0.23. Bath & Body Works had a negative return on equity of 31.34% and a net margin of 10.58%. The firm had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.81 billion. As a group, research analysts predict that Bath & Body Works, Inc. will post 2.96 EPS for the current fiscal year.

Bath & Body Works Company Profile

(Get Rating)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.